Immunotherapy for Murine K1735 Melanoma: Combinatorial Use of Recombinant Adenovirus Expressing CD40L and Other Immunomodulators

Cancer Gene Therapy - United Kingdom
doi 10.1038/sj.cgt.7700475
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Melanoma Immunotherapy Using Mature DCs Expressing the Constitutive Proteasome

Journal of Clinical Investigation
Medicine
2013English

Construction and Characterization of a Recombinant Human Adenovirus Vector Expressing Bone Morphogenetic Protein 2

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2013English

Combination Immunotherapy for Melanoma

JAMA Oncology
Cancer ResearchOncology
2015English

The Use of Immunotherapy in the Treatment of Melanoma

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2017English

Advances in Immunotherapy for Melanoma

BMC Medicine
Medicine
2016English

833 High-Dose Recombinant Interferon-Α1b: An Effective Immunotherapy With Low Toxicity for Melanoma Patients

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Effective Antitumor Immunity Against Murine Gliomas Using Dendritic Cells Transduced With hTERTC27 Recombinant Adenovirus

Oncology Reports
MedicineCancer ResearchOncology
2011English

Construction and Immunogenicity of Recombinant Adenovirus Vaccines Expressing the HMW1, HMW2, or Hia Adhesion Protein of Nontypeable Haemophilus Influenzae

Clinical and Vaccine Immunology
MedicineImmunologyAllergyClinical BiochemistryMicrobiology
2010English

Melanoma Immunotherapy: Mechanisms and Opportunities

Investigative Dermatology and Venereology Research
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy